Additional file 1 of Efficacy of chloroquine versus lopinavir/ritonavir in mild/general COVID-19 infection: a prospective, open-label, multicenter, randomized controlled clinical study
ABSTRACT Introduction: Pro-inflammatory markers play a significant role in the disease severity of patients with COVID-19. Thus, anti-inflammatory therapies are attractive agents for potentially com
These are peer-reviewed supplementary materials for the article 'COVID-19 clinical trials: who is likely to participate and why?' published in the Journal of Comparative Effectiveness Research.Appendi
